Polynovo Ltd
ASX:PNV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Polynovo Ltd
Cash & Cash Equivalents
Polynovo Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Polynovo Ltd
ASX:PNV
|
Cash & Cash Equivalents
AU$29.2m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
31%
|
CAGR 10-Years
34%
|
|
|
Nanosonics Ltd
ASX:NAN
|
Cash & Cash Equivalents
AU$33.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
20%
|
CAGR 10-Years
16%
|
|
|
SDI Ltd
ASX:SDI
|
Cash & Cash Equivalents
AU$4.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
2%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ansell Ltd
ASX:ANN
|
Cash & Cash Equivalents
$250.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
Cash & Cash Equivalents
$2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Polynovo Ltd
Glance View
Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.
See Also
What is Polynovo Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
29.2m
AUD
Based on the financial report for Dec 31, 2025, Polynovo Ltd's Cash & Cash Equivalents amounts to 29.2m AUD.
What is Polynovo Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
34%
Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for Polynovo Ltd have been -17% over the past three years , 31% over the past five years , and 34% over the past ten years .
